Magellan Executives Charged with Conspiracy, Wire Fraud, and FDA Violations
Three former executives of Magellan Diagnostics, Inc. (Magellan) were recently charged in connection with concealing a device…
Author
Bipartisan Senators Ask for Additional Guidance on Transparency in Coverage…
Recently, a bipartisan duo of United States Senators sent a letter to the Centers for Medicare and Medicaid Services (CMS)…
Congress Seeking Answers on Hospital Price Transparency Rule Compliance
Recently, members of the United States of Representatives’ Energy and Commerce Committee Subcommittee on Health held a hearing on…
CMS Fines Hospital for Noncompliance with Hospital Price Transparency Rule
Recently, the Centers for Medicare and Medicaid Services (CMS) issued a Hospital Price Transparency Notice of Imposition of a…
House Subcommittee Focuses on Antimicrobial Resistance
On April 28, 2023, the United States House of Representatives Oversight and Investigations Subcommittee held a hearing on…
SouthEast Eye Specialists to Pay $17 Million to Resolve Anti-Kickback and…
It was recently announced that SouthEast Eye Specialists (SEES), along with affiliated surgery centers SouthEast Eye Surgery…
FDA to Require Mail-Back Envelopes for Opioids Dispensed in Outpatient…
Recently, the United States Food and Drug Administration (FDA) announced that it will start requiring manufacturers of opioid…
CCO MATE ACT DEA Resource Center Includes, Courses, Frequently Asked…
In December 2022, congress passed the MATE Act which starting June 27, 2023 will require all DEA certificate holders to have…
OPDP: No More Untitled Letters?
Today marks one year since the Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) issued an Untitled…
PhRMA Releases Report on Global Prescription Drug Access
The Pharmaceutical Research and Manufacturers of America (PhRMA) recently published a new report that analyzes the share of new…